Novavax（NASDAQ:NVAX）公佈的季度虧損爲每股$(1.23)，高於分析師一致預期的$(1.32)，超過預期6.82%。與去年同期每股虧損$(5.41)相比，這增加了77.26%。公司公佈的季度銷售額爲$6.8216億，低於分析師一致預期的$6.8494億，低於預期0.41%。與去年同期$9.8371億的銷售額相比，下降了30.65%。
以上內容來自Benzinga Earnings專欄，原文如下：
Novavax (NASDAQ:NVAX) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.32) by 6.82 percent. This is a 77.26 percent increase over losses of $(5.41) per share from the same period last year. The company reported quarterly sales of $682.16 million which missed the analyst consensus estimate of $684.94 million by 0.41 percent. This is a 30.65 percent decrease over sales of $983.71 million the same period last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。